Halozyme Reports Second Quarter 2017 Results

Go back to Halozyme Reports Second Quarter 2017 Results
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 102.62 --0 (-0%)
Previous Close $102.62    52 Week High $18.39 
Open $103.61    52 Week Low $6.96 
Day High $104.78    P/E N/A 
Day Low $101.81    EPS $-0.58 
Volume 2,846,007